These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25267885)

  • 21. Role of CYP2B6 pharmacogenomics in bupropion-mediated smoking cessation.
    Tran AX; Ho TT; Varghese Gupta S
    J Clin Pharm Ther; 2019 Apr; 44(2):174-179. PubMed ID: 30578565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human genetics: international projects and personalized medicine.
    Apellaniz-Ruiz M; Gallego C; Ruiz-Pinto S; Carracedo A; Rodríguez-Antona C
    Drug Metab Pers Ther; 2016 Mar; 31(1):3-8. PubMed ID: 26581075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
    Tavakolpour S; Darvishi M; Ghasemiadl M
    Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomics and pharmacogenomics of brain disorders.
    Cacabelos R; Martinez-Bouza R; Carril JC; Fernandez-Novoa L; Lombardi V; Carrera I; Corzo L; McKay A
    Curr Pharm Biotechnol; 2012 Apr; 13(5):674-725. PubMed ID: 22122480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomics of methadone: a narrative review of the literature.
    Packiasabapathy S; Aruldhas BW; Horn N; Overholser BR; Quinney SK; Renschler JS; Sadhasivam S
    Pharmacogenomics; 2020 Aug; 21(12):871-887. PubMed ID: 32705966
    [No Abstract]   [Full Text] [Related]  

  • 27. 6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy.
    Stojiljkovic M; Fazlagic A; Dokmanovic-Krivokapic L; Nikcevic G; Patrinos GP; Pavlovic S; Zukic B
    Hum Genomics; 2012 Sep; 6(1):19. PubMed ID: 23157848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.
    Marie-Claire C; Jourdaine C; Lépine JP; Bellivier F; Bloch V; Vorspan F
    Pharmacogenomics; 2017 Sep; 18(14):1359-1372. PubMed ID: 28841113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics.
    Gomase VS; Tagore S; Changbhale SS; Kale KV
    Curr Drug Metab; 2008 Mar; 9(3):207-12. PubMed ID: 18336223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized medicine and tobacco-related health disparities: is there a role for genetics?
    Carlsten C; Halperin A; Crouch J; Burke W
    Ann Fam Med; 2011; 9(4):366-71. PubMed ID: 21747109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Pharmacogenomics in Personalized Medicine.
    Singh DB
    Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Institute on Drug Abuse genomics consortium white paper: Coordinating efforts between human and animal addiction studies.
    Cates HM; Benca-Bachman CE; de Guglielmo G; Schoenrock SA; Shu C; Kallupi M
    Genes Brain Behav; 2019 Jul; 18(6):e12577. PubMed ID: 31012252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine dependence and depression among methadone maintenance patients.
    Meyer TJ; Lin MM; Brown LS
    J Natl Med Assoc; 1996 Dec; 88(12):800-4. PubMed ID: 8990806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of pharmacogenetics and pharmacogenomics on drug discovery.
    Lindpaintner K
    Nat Rev Drug Discov; 2002 Jun; 1(6):463-9. PubMed ID: 12119748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interest in smoking cessation among methadone maintained outpatients.
    Frosch DL; Shoptaw S; Jarvik ME; Rawson RA; Ling W
    J Addict Dis; 1998; 17(2):9-19. PubMed ID: 9567223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study.
    Wu LT; Blazer DG; Stitzer ML; Patkar AA; Blaine JD
    Am J Addict; 2008; 17(4):304-11. PubMed ID: 18612886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
    Kennedy MA; Joyce PR; Begg EJ
    Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bupropion in cigarettes smoking cessation by former polydrug user participating in methadone maintenance programme].
    Steinbarth-Chmielewska K; Habrat B
    Przegl Lek; 2005; 62(10):1126. PubMed ID: 16521970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current situation of substance abuse/dependence in psychiatric hospital settings].
    Ozaki S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Feb; 39(1):35-40. PubMed ID: 15058092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.